Roquefort Therapeutics plc (LON: ROQ)
London
· Delayed Price · Currency is GBP · Price in GBX4.300
+0.350 (8.86%)
Nov 22, 2024, 5:04 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 5.55 million as of November 22, 2024. Its market cap has decreased by -38.57% in one year.
Market Cap
5.55M
Enterprise Value
5.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.30
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 5.55M, an increase of 153.93%. That is a compound annual growth rate of 28.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 5.10M | -45.52% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
| Mar 22, 2021 | 2.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 155.99B |
| GSK plc | 53.43B |
| Haleon plc | 33.71B |
| Smith & Nephew plc | 8.51B |
| ConvaTec Group PLC | 4.72B |
| Hikma Pharmaceuticals PLC | 4.15B |
| Oxford Nanopore Technologies plc | 1.17B |
| Animalcare Group plc | 148.52M |